EXICURE, M&A Friday, November 20, 2026 +0.65 Positive

Exicure invests in X-CUE smart glasses for Parkinson's

Exicure agreed to acquire stakes in NeuroQ and Laonz for its Parkinson's smart glass technology, X-CUE, ready for clinical trials following the transfer of IP and assets.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed